维普中文期刊产品整合服务
49篇 您的检索式:作者名="Oldhafer"
    题名 作者 年代 出处 被引量
1Current position of ALPPS in the surgical landscape of CRLM treatment proposals显示文摘The Authors summarize problems,criticisms but also advantages and indications regarding the recent surgical proposal of associating liver partition and portal vein ligation(PVL)for staged hepatectomy(ALPPS)for the surgical management of colorectal liver metastases.Looking at published data,the technique,when compared with other traditional and well established methods such as PVL/portal vein embolisation(PVE),seems to give real advantages in terms of volumetric gain of future liver remnant.However,major concerns are raised in the literature and some questions remain unanswered,preliminary experiences seem to be promising.The method has been adopted all over the world over the last 2 years,even if oncological long-term results remain unknown,and benefit for patients is questionable.No prospective studies comparing traditional methods(PVE,PVL or classical 2 staged hepatectomy)with ALPPS are available to date.Technical reinterpretations of the original method were also proposed in order to enhance feasability and increase safety of the technique.More data about morbidity and mortality are also expected.The real role of ALPPS is,to date,still to be established.Large clinical studies,even if,for ethical reasons,in well selected cohorts of patients,are expected to better define the indications for this new surgical strategy.Marcello Donati Gregor A Stavrou Karl J Oldhafer 2013World Journal of Gastroenterology2013,19,39:16
2Laparoscopic step 1 ALPPS with microwave transection of theliver for Klatskin tumors:Is it worthwhile?显示文摘To the Editor:Associating liver partition and portal vein ligation for staged hepatectomy(ALPPS)was introduced in 2007[1].This technique is now used worldwide and has a wide spectrum of indications.However,scientific debate and un-regulated surgical experimentation concerning the application of this technique led the surgeons to organize the first Consensus Meeting[2]to build a scientific consensus.One of the most controversial indications to ALPPS is its application for Klatskin tumors.The aim of this letter is to ana-marcello donati francesco basile karl j oldhafer 2018Hepatobiliary & Pancreatic Diseases International2018,17,3:4
3Immunological aspects of liver cell transplantation显示文摘Within the field of regenerative medicine, the liver is of major interest for adoption of regenerative strategies due to its well-known and unique regenerative capacity. Whereas therapeutic strategies such as liver resection and orthotopic liver transplantation(OLT) can be considered standards of care for the treatment of a variety of liver diseases, the concept of liver cell transplantation(LCTx) still awaits clinical breakthrough. Success of LCTx is hampered by insufficient engraftment/long-term acceptance of cellular allografts mainly due to rejection of transplanted cells. This is in contrast to the results achieved for OLT where longterm graft survival is observed on a regular basis and, hence, the liver has been deemed an immuneprivileged organ. Immune responses induced by isolated hepatocytes apparently differ considerably from those observed following transplantation of solid organs and, thus, LCTx requires refined immunological strategies to improve its clinical outcome. In addition, clinical usage of LCTx but also related basic research efforts are hindered by the limited availability of high quality liver cells, strongly emphasizing the need for alternative cell sources. This review focuses on the various immunological aspects of LCTx summarizing data available not only for hepatocyte transplantation but also for transplantation of non-parenchymal liver cells and liver stem cells.Felix Oldhafer Michael Bock Christine S Falk Florian WR Vondran 2016World Journal of Transplantation2016,6,1:3
4Long-term experience af- ter ex situ liver surgery显示文摘Oldhafer KJ Lang H Schlitt HJ 2000Surgery2000,127,5:1
5Two-step procedure in Budd-Chiari syndrome with severe intrahepatic Vena cava stenosis:Vena cava stenting and portocaval shunt显示文摘Oldhafer KJ Frerker M Prokop M 1998Am J Gastroenterol1998,93,7:1
6Long-term experience after ex situ liver surgeu显示文摘KJ Oldhafer H Lang HJ Schlitt 2000Surgery2000,127,5:1
7Ex vivo resection techniques in tissue-preserving surgery for liver malignancies显示文摘Raab R Schlitt HJ Oldhafer KJ 2000Langenbecks Arch Surg2000,385,3:1
8ALPPS-where do we stand, where do we go?: eight recommendations from the first international expert meeting显示文摘Oldhafer K J Stavrou GA van Gulik TM 2016Ann Surg2016,263,5:1
9Appraisal of transplantation of malignant tumors of liver special reference to early stage hepatocelluar carcinoma显示文摘Pichmayer R Weimann A Oldhafer KJ 1998Eur J Surg Oncol1998,24,:1
10Long-term experience after ex s itu liver surgery显示文摘Oldhafer K J Lang H Schlitt H J 2000Surgery2000,127,5:1
11Liver transplantation for metastatic neuoendocrine tumors显示文摘Lang H Oldhafer KJ Weimann A 1997Ann Surg1997,225,:1
12Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: 1-dentification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue显示文摘Strassburg CP Oldhafer K Manns MP 1997Mol Pharmaeol1997,52,:1
13ALPPS far Patients with Colorectal Liv- er Metastases: Effective Liver Hypertrophy, but Early Tumor R ecurrence 显示文摘Oldhafer KJ Donati M 2014World J Surg2014,38,6:1
143-dimensional (3-D) visualization of theliver for planning extensive liver resections显示文摘Oldhafer KJ Hogemann D Stamm G 1999Chirurg1999,70,3:1
15Long term experience after ex situ liver surgery显示文摘Oldhafer KJ Lang H Sehlitt HI 2000Surgery2000,127,5:1
16Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma显示文摘Pichlmayr R Weimann A Oldhafer K J Schlitt H J Tusch G Raab R European Journal of Surgical Oncology0,,:1
17Background and prognostic implications of perireperfusion tissue injuries in human liver transplants:a panel histochemical study显示文摘KIUCHI T OLDHAFER K J SCHLITT H J 1998Transplantation1998,66,6:1
18Liver remnant hypertrophy induction – How often do we really use it in the time of computer assisted surgery?显示文摘GA Stavrou M Donati KI Ringe HO Peitgen KJ Oldhafer 2012Advances in Medical Sciences2012,,2:1
19ALPPS for patientswith colorectal liver metastases : effective liver hypertrophy, butearly tumor recurrence 显示文摘Oldhafer KJ Donati M Jenner RM 2014World J Surg2014,38,6:1
20Longtermexperience after ex situ liver surgery 显示文摘OLDHAFER K J LANG H SCHUTT H J 2000Surgery2000,127,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费